Depression and Sleep Quality among Iranian Women with Breast Cancer.
BDI
PSQI
Sleep Quality
breast cancer
depression
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Nov 2021
01 Nov 2021
Historique:
received:
30
10
2020
entrez:
28
11
2021
pubmed:
29
11
2021
medline:
11
2
2022
Statut:
epublish
Résumé
Breast cancer causes many psychological disorders such as sleep disturbances and depression. The current study was, therefore, intended to describe sleep quality and depression and to identify the association between these two psychological disorders among Iranian women with breast cancer. This descriptive, analytical, cross-sectional study was carried out on 120 women with non-metastatic unilateral breast cancer undergoing chemotherapy in an outpatient chemotherapy unit of a major public hospital. A total of 120 women who had already undergone mastectomy procedure were selected via convenience sampling method. Data were collected by the Beck Depression Inventory-II (BDI-II) and the Pittsburgh Sleep Quality Index (PSQI). The mean score on BDI-II was 13.40 (± 6.51), and 30% (n=36) of women had mild depression and 14.2% (n=17) reported moderate-to-severe depression. The mean global score of sleep quality was found to be 6.48 (± 2.62). Furthermore, 50.8% (n=61) of women obtained a global PSQI score of 5. A positive correlation was found between depression scores and sleep quality scores (p=0.001, r= 0.48). Depression was also correlated with age, number of children, household gross income, sleep duration, sleep latency, and type of mastectomy procedure (p<0.05). Moreover, subjective sleep quality was correlated with number of chemotherapy sessions (p=0.001, r=-0.67) and daytime dysfunction (p=0.001, r=0.78). A positive correlation was also observed between sleep disturbances and habitual sleep efficiency (p = 0.02, r = 0.65). In conclusion, 30% of women had mild depression and 14.2% reported moderate-to-severe depression. The mean global score of sleep quality was found to be 6.48 (± 2.62), suggesting poor sleep quality. Furthermore, over half of the participants (50.8%) obtained a global PSQI score of 5 or greater which is indicative of poor sleep quality. A positive moderate correlation was also observed between depression and poor sleep quality.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Breast cancer causes many psychological disorders such as sleep disturbances and depression. The current study was, therefore, intended to describe sleep quality and depression and to identify the association between these two psychological disorders among Iranian women with breast cancer.
MATERIALS AND METHODS
METHODS
This descriptive, analytical, cross-sectional study was carried out on 120 women with non-metastatic unilateral breast cancer undergoing chemotherapy in an outpatient chemotherapy unit of a major public hospital. A total of 120 women who had already undergone mastectomy procedure were selected via convenience sampling method. Data were collected by the Beck Depression Inventory-II (BDI-II) and the Pittsburgh Sleep Quality Index (PSQI).
RESULTS
RESULTS
The mean score on BDI-II was 13.40 (± 6.51), and 30% (n=36) of women had mild depression and 14.2% (n=17) reported moderate-to-severe depression. The mean global score of sleep quality was found to be 6.48 (± 2.62). Furthermore, 50.8% (n=61) of women obtained a global PSQI score of 5. A positive correlation was found between depression scores and sleep quality scores (p=0.001, r= 0.48). Depression was also correlated with age, number of children, household gross income, sleep duration, sleep latency, and type of mastectomy procedure (p<0.05). Moreover, subjective sleep quality was correlated with number of chemotherapy sessions (p=0.001, r=-0.67) and daytime dysfunction (p=0.001, r=0.78). A positive correlation was also observed between sleep disturbances and habitual sleep efficiency (p = 0.02, r = 0.65).
CONCLUSION
CONCLUSIONS
In conclusion, 30% of women had mild depression and 14.2% reported moderate-to-severe depression. The mean global score of sleep quality was found to be 6.48 (± 2.62), suggesting poor sleep quality. Furthermore, over half of the participants (50.8%) obtained a global PSQI score of 5 or greater which is indicative of poor sleep quality. A positive moderate correlation was also observed between depression and poor sleep quality.
Identifiants
pubmed: 34837896
doi: 10.31557/APJCP.2021.22.11.3433
pmc: PMC9068183
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3433-3440Références
Arch Iran Med. 2017 Nov 01;20(11 Suppl. 1):S59-S62
pubmed: 29481130
Appl Nurs Res. 2017 Apr;34:7-11
pubmed: 28342628
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Pain Symptom Manage. 2012 Aug;44(2):215-28
pubmed: 22795049
Maturitas. 2017 Nov;105:126-131
pubmed: 28268037
Depress Anxiety. 2005;21(4):185-92
pubmed: 16075452
Rep Pract Oncol Radiother. 2013 May 24;18(4):193-200
pubmed: 24416553
J Womens Health (Larchmt). 2021 Nov;30(11):1604-1615
pubmed: 33035108
PLoS One. 2014 Nov 25;9(11):e112733
pubmed: 25423095
Drug Discov Today Dis Models. 2011 Winter;8(4):167-173
pubmed: 22140397
Support Care Cancer. 2019 Apr;27(4):1365-1373
pubmed: 30112722
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S454-66
pubmed: 22588766
Psychooncology. 2010 Oct;19(10):1069-77
pubmed: 20014073
Iran J Public Health. 2018 Mar;47(3):309-316
pubmed: 29845017
J Breast Health. 2016 Jul 1;12(3):94-101
pubmed: 28331743
Palliat Support Care. 2018 Jun;16(3):325-334
pubmed: 28508735
Support Care Cancer. 2018 Jun;26(6):1695-1698
pubmed: 29484499
Arch Iran Med. 2017 Nov 01;20(11 Suppl. 1):S11-S14
pubmed: 29481118
Nurs Open. 2021 May;8(3):1030-1037
pubmed: 34482659
Rev Saude Publica. 2019 Apr 01;53:30
pubmed: 30942272
Asian Pac J Cancer Prev. ;18(7):1889-1896
pubmed: 28749617
Medicine (Baltimore). 2019 Apr;98(16):e15301
pubmed: 31008981
J Relig Health. 2017 Apr;56(2):575-590
pubmed: 27287259
Psychosomatics. 2018 May - Jun;59(3):251-258
pubmed: 29525523
Arch Iran Med. 2017 Nov 01;20(11 Suppl. 1):S79-S82
pubmed: 29481135
J Natl Med Assoc. 2013 Spring;105(1):4-15
pubmed: 23862291
J Pain Symptom Manage. 2015 Apr;49(4):707-15
pubmed: 25461671
World J Surg. 2018 Jul;42(7):2076-2085
pubmed: 29426972
Mol Psychiatry. 2020 Jul;25(7):1487-1499
pubmed: 31745237
Support Care Cancer. 2018 Jun;26(6):1833-1840
pubmed: 29264658
Support Care Cancer. 2016 Oct;24(10):4197-205
pubmed: 27146391
PLoS One. 2017 Apr 10;12(4):e0175395
pubmed: 28394909
J Psychiatr Res. 2021 Nov;143:481-484
pubmed: 33261819
J Clin Sleep Med. 2018 Jan 15;14(1):81-86
pubmed: 29198300
Acta Oncol. 2009;48(8):1128-36
pubmed: 19863220
Support Care Cancer. 2014 Sep;22(9):2535-45
pubmed: 24733634
Cancer. 2019 Dec 15;125(24):4516-4524
pubmed: 31553501
Neuropsychiatr Dis Treat. 2019 Dec 24;15:3519-3529
pubmed: 31920312
Arch Iran Med. 2017 Nov 01;20(11 Suppl. 1):S83-S86
pubmed: 29481136
Sleep Breath. 2012 Mar;16(1):79-82
pubmed: 21614577
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Integr Cancer Ther. 2017 Jun;16(2):196-204
pubmed: 27154183
BMC Public Health. 2016 Oct 19;16(1):1098
pubmed: 27760538
J Oncol Pract. 2016 Aug;12(8):747-56
pubmed: 27382000
Health Psychol. 2018 Nov;37(11):1035-1040
pubmed: 30265046